Literature DB >> 10198181

Glucose utilization and glycogen turnover are accelerated in hypertrophied rat hearts during severe low-flow ischemia.

R B Wambolt1, S L Henning, D R English, Y Dyachkova, G D Lopaschuk, M F Allard.   

Abstract

We undertook this study to determine if the metabolism of exogenous glucose and glycogen in hypertrophied hearts differed from that in normal hearts during severe ischemia. Thus, rates of glycolysis (3H2O production) and oxidation (14CO2 production) from exogenous glucose and glycogen were measured in isolated working control (n = 13) and hypertrophied (n = 12) hearts from sham-operated and aortic-banded rats during 40 min of severe low-flow ischemia. Hearts, in which glycogen was prelabelled with [5-3H]- or [14C]-glucose, were paced and perfused with Krebs-Henseleit solution containing 1.2 mM palmitate, 5.5 mM [5-3H]- or [14C]-glucose (different from the isotope used to label glycogen), 0.5 mM lactate and 100 microU/ml insulin during ischemia. Rates of glycolysis from exogenous glucose (3301 +/- 122 v 2467 +/- 167 nmol/min/g dry wt, mean +/- S.E.M., P < 0.05) and glucose from glycogen (808 +/- 27 v 725 +/- 21 nmol/min/g dry wt, P < 0.05) were accelerated in hypertrophied hearts compared to control hearts. However, rates of oxidation of exogenous glucose and glucose from glycogen were not significantly different between the two groups. As observed in normoxic non-ischemic hearts, glucose from glycogen was preferentially oxidized compared to exogenous glucose. Additionally, rates of glycogen synthesis (167 +/- 7 v 140 +/- 9 nmol/min/g dry wt, P < 0.05) were increased in hypertrophied hearts compared to control hearts during severe low-flow ischemia indicating that glycogen turnover (i.e. simultaneous synthesis and degradation) was accelerated in the hypertrophied heart. Thus, we demonstrate that glucose utilization and glycogen turnover are accelerated in the hypertrophied heart during severe low-flow ischemia as compared to the normal heart.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10198181     DOI: 10.1006/jmcc.1998.0804

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  19 in total

1.  Responses of hypertrophied myocytes to reactive species: implications for glycolysis and electrophile metabolism.

Authors:  Brian E Sansbury; Daniel W Riggs; Robert E Brainard; Joshua K Salabei; Steven P Jones; Bradford G Hill
Journal:  Biochem J       Date:  2011-04-15       Impact factor: 3.857

Review 2.  Cardiac carbon 13 magnetic resonance spectroscopy: on the horizon or over the rainbow?

Authors:  E Douglas Lewandowski
Journal:  J Nucl Cardiol       Date:  2002 Jul-Aug       Impact factor: 5.952

3.  The Role of Nonglycolytic Glucose Metabolism in Myocardial Recovery Upon Mechanical Unloading and Circulatory Support in Chronic Heart Failure.

Authors:  Rachit Badolia; Dinesh K A Ramadurai; E Dale Abel; Peter Ferrin; Iosif Taleb; Thirupura S Shankar; Aspasia Thodou Krokidi; Sutip Navankasattusas; Stephen H McKellar; Michael Yin; Abdallah G Kfoury; Omar Wever-Pinzon; James C Fang; Craig H Selzman; Dipayan Chaudhuri; Jared Rutter; Stavros G Drakos
Journal:  Circulation       Date:  2020-04-30       Impact factor: 29.690

Review 4.  Glucose Transporters in Cardiac Metabolism and Hypertrophy.

Authors:  Dan Shao; Rong Tian
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

Review 5.  Energy metabolism in the hypertrophied heart.

Authors:  Nandakumar Sambandam; Gary D Lopaschuk; Roger W Brownsey; Michael F Allard
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

Review 6.  AMPK alterations in cardiac physiology and pathology: enemy or ally?

Authors:  Jason R B Dyck; Gary D Lopaschuk
Journal:  J Physiol       Date:  2006-05-11       Impact factor: 5.182

7.  Pyruvate dehydrogenase and the regulation of glucose oxidation in hypertrophied rat hearts.

Authors:  Carmen P Lydell; Andy Chan; Richard B Wambolt; Nandakumar Sambandam; Hannah Parsons; Gregory P Bondy; Brian Rodrigues; Kirill M Popov; Robert A Harris; Roger W Brownsey; Michael F Allard
Journal:  Cardiovasc Res       Date:  2002-03       Impact factor: 10.787

Review 8.  Glucose metabolism and cardiac hypertrophy.

Authors:  Stephen C Kolwicz; Rong Tian
Journal:  Cardiovasc Res       Date:  2011-05-01       Impact factor: 10.787

Review 9.  Metabolic shifts during aging and pathology.

Authors:  Yina Ma; Ji Li
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

Review 10.  Fuel availability and fate in cardiac metabolism: A tale of two substrates.

Authors:  Florencia Pascual; Rosalind A Coleman
Journal:  Biochim Biophys Acta       Date:  2016-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.